Zentek Ltd. Files 6-K Report
Ticker: ZTEK · Form: 6-K · Filed: Mar 25, 2024 · CIK: 1904501
| Field | Detail |
|---|---|
| Company | Zentek Ltd. (ZTEK) |
| Form Type | 6-K |
| Filed Date | Mar 25, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: regulatory-filing, foreign-private-issuer, sec-form-6k
TL;DR
Zentek Ltd. filed a 6-K, confirming Canadian issuer status (Form 40-F).
AI Summary
Zentek Ltd. filed a Form 6-K on March 25, 2024, reporting as a foreign private issuer. The company is incorporated in Canada and has its principal executive offices in Guelph, Ontario. This filing indicates Zentek Ltd. is submitting its report under Form 40-F, which is typically used for annual reports by Canadian issuers.
Why It Matters
This filing provides an update on Zentek Ltd.'s reporting status with the SEC, confirming its adherence to regulatory requirements for foreign private issuers.
Risk Assessment
Risk Level: low — This is a routine regulatory filing and does not contain new financial or operational information that would typically indicate a change in risk.
Key Players & Entities
- Zentek Ltd. (company) — Registrant
- 20240325 (date) — Filing Date
- 001-41310 (other) — Commission File Number
- Form 40-F (other) — Annual Report Form
FAQ
What type of filing is this Form 6-K?
This Form 6-K is a Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934.
What is the company's name and location?
The company's name is Zentek Ltd., and its principal executive offices are located at 24 Corporate Court, Guelph, Ontario, Canada.
What is the Commission File Number for Zentek Ltd.?
The Commission File Number for Zentek Ltd. is 001-41310.
Which annual report form does Zentek Ltd. indicate it files or will file?
Zentek Ltd. indicates it files or will file annual reports under cover of Form 40-F.
What is the SIC code for Zentek Ltd.?
The Standard Industrial Classification (SIC) code for Zentek Ltd. is 2890, which falls under Miscellaneous Chemical Products.
Filing Stats: 206 words · 1 min read · ~1 pages · Grade level 11.4 · Accepted 2024-03-25 10:03:10
Filing Documents
- form6k.htm (6-K) — 7KB
- exhibit99-1.htm (EX-99.1) — 8KB
- exhibit99-1x001.jpg (GRAPHIC) — 6KB
- exhibit99-1x002.jpg (GRAPHIC) — 5KB
- 0001062993-24-006979.txt ( ) — 31KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. ZENTEK LTD. (Registrant) Date: March 25, 2024 By /s/ Wendy Ford Wendy Ford Chief Financial Officer EXHIBIT INDEX Exhibit Description of Exhibit 99.1 Press Release dated March 25, 2024 - Zentek Announces Promising Preclinical Safety and Toxicity Results achieved by Triera Bisosciences Ltd. for C19HBA